Status:
COMPLETED
Phytosterol Supplementation and Cardiovascular Risk
Lead Sponsor:
The Cooper Institute
Collaborating Sponsors:
Cargill
Conditions:
Hypercholesteremia
Eligibility:
All Genders
20-70 years
Phase:
NA
Brief Summary
This study examined the effects of 2.6 g/d of phytosterol ingestion on LDL cholesterol metabolism. It is expected that this dose will significantly reduce LDL cholesterol after 12 weeks of supplementa...
Detailed Description
This study examined the effects of 2.6 g/d of phytosterol ingestion on LDL cholesterol metabolism. It is expected that this dose will significantly reduce LDL cholesterol after 12 weeks of supplementa...
Eligibility Criteria
Inclusion
- mild hypercholesteremia, sign informed consent, not donate blood, maintain diet and exercise habits
Exclusion
- BMI \<18.5 or \>34.9, recent blood donation, serious or life-threatening disease
Key Trial Info
Start Date :
March 1 2004
Trial Type :
INTERVENTIONAL
End Date :
August 1 2005
Estimated Enrollment :
72 Patients enrolled
Trial Details
Trial ID
NCT00153738
Start Date
March 1 2004
End Date
August 1 2005
Last Update
March 13 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The Cooper Institute
Dallas, Texas, United States, 75230